Home Life Sciences Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
Article Open Access

Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations

  • Min Lin , Cuiyun Li , Chao Lin , Shangquan Xiong , Qiao Xue EMAIL logo and Yang Li EMAIL logo
Published/Copyright: November 3, 2023

Abstract

The purpose of this study was to determine the effect of amiodarone (Ami) on hERG-T618I currents in HEK293 cells. A transient transfection method was used to transfer hERG-T618I and hERG wild-type (WT) channel plasmids into HEK293 cells. An extracellular local perfusion method was used for administration. Currents were recorded using the whole-cell patch clamp technique. Ami (10 μM) had a greater retarding effect on the hERG-T618I channel than WT (P < 0.05). The half-inhibitory concentration for the mutant was approximately 1.82 times that of WT (P < 0.05). The WT current inhibition fraction against Ami was significantly greater than T618I in the same cell (P < 0.05). The STEP current of the mutant channel was larger than the WT channel, but the characteristic of inward rectification did not appear. Ami reduced the STEP current of the mutant channel, and the steady-state activation curve indicated that channel activation decreased (P > 0.05). Ami restored partial inactivation of the mutant channel. Ami effectively reduced the current in the phase 2 plateau (P < 0.05), but the phase 3 current did not exhibit the characteristics of a WT current. Ami inhibited hERG-T618I currents on HEK293 cells, but the effect was weaker than WT.

Graphical abstract

Ami (10 μM) had a greater retarding effect on the hERG-T618I channel than WT (P < 0.05). The half-inhibitory concentration for the mutant (4.56 μM) was approximately 1.82 times that of WT (2.51 μM).

1 Introduction

The human ether-à-go-go-related gene (hERG) encodes the pore-forming α-subunit of the rapidly activating delayed rectifier potassium channel (I Kr) in cardiomyocytes [1,2]. The KCNE2 gene encodes the β-subunit (MiRP1) of the I Kr channel [1,2]. The two subunits assemble to form wild-type (WT) I Kr, which conducts the major current responsible for action potential (AP) repolarization in cardiomyocytes and contributes to phase 3 of the repolarization process [1,2]. The magnitude of the I Kr current determines the cardiomyocyte AP duration. The larger the current, the shorter the cardiomyocyte AP duration; otherwise, the AP duration is prolonged [3]. Therefore, the hERG-T618I gain-of-function mutation results in an increased density of the I Kr current and the short QT syndrome [SQTS] [4]. The I Kr current is the major current inducing electrical remodeling in several heart diseases and is closely related to malignant arrhythmias and sudden cardiac death [5]. The I Kr current is also the primary target for class III antiarrhythmic drugs [5]; however, the SQTS caused by hERG mutations is refractory to class III antiarrhythmic drugs, such as sotalol and ibutilide, but moderately sensitive to class Ia antiarrhythmics, such as quinidine and disopyramide [6].

Amiodarone (Ami) is a potent drug that has been extensively used against fast arrhythmias in the clinical setting for nearly 30 years. With high efficacy and a low pro-arrhythmogenic effect, Ami occupies an important position among antiarrhythmic drugs and has been recommended as first-line therapy in many guidelines, despite the associated toxicity [7,8]. Ami is a class Ⅲ antiarrhythmic that blocks multiple potassium channels, including the I Kr, the slowly activating delayed rectifier potassium current (I Ks), and the transient outward potassium current [I to] [9,10]. The hERG-T618 gain-of-function mutation is associated with a distinctly impaired sensitivity to several antiarrhythmics compared to WT hERG [11]. Thus, the hERG-T618 gain-of-function mutation has a direct impact on the efficacy of antiarrhythmics [11]; however, sensitivity to Ami in the presence of a hERG-T618 gain-of-function mutation has not been reported. We compared sensitivity to Ami with and without a hERG-T618I gain-of-function mutation, thus providing experimental clues to promote rational drug use.

2 Materials and methods

2.1 Drugs and reagents

HEPES, pronase E, l-glutamic acid, K-aspartate, GTP, CdCl2, TTX, CsCl, and dofetilide were purchased from Sigma-Aldrich (St. Louis, MO, USA). EGTA and DMEM were purchased from Solarbio (Beijing, China). Fetal bovine serum, lipofectamine transcription reagent, and green fluorescent protein (GFP) were purchased from Invitrogen (Carlsbad, CA, USA).

Ami (MW = 681.77) was purchased from Sigma-Aldrich. Ami was dissolved in dimethyl sulfoxide and made into a stock solution, which was later diluted using extracellular solution to 6 different concentrations (0.1, 0.3, 1.0, 3.0, 10.0, and 30.0 μM). The Ami solution was administered in the extracellular constant current perfusion mode using a local perfusion device. To detect the effect of DMSO on current, I hERG current was recorded when extracellular solution contained 0 (total solution volume: 3,000 μL) and 25.0 μL (total solution volume: 3,025 μL, 0.82% v/v), respectively, and it was not found that there was a significant change in current amplitude under the two conditions (n = 5, P > 0.05). In this experiment, local perfusion model of cells was used with a local perfusion device. To achieve the equilibrium of drug concentration in extracellular solution and the steady effect of Ami on current, I hERG current was recorded after 5 min of drug perfusion at room temperature (23–25°C).

The amplitude of the tail current before and after drug application was recorded in the same cell, and the current density was calculated using the cell capacitance. The percent inhibition of the peak tail current by Ami was measured. Inhibition fraction of drug (%) = (I beforeI after)/I before × %; I before is the amplitude of the tail current before drug application and I after is the amplitude of the tail current after drug application. Then, the inhibition fraction (%) of the tail currents was compared between WT and T618I. We also determined tail-current activation kinetics and calculated the activation time constant (tau) using an exponential fitting (I = I∞[1 − exp (1 − t/tau)]. The voltage dependence of WT and T618I channel activation was compared.

2.2 Solution preparation

The pipette solution contained (mmol/L): K-aspartate, 140; MgATP, 4; MgCl2, 1; EGTA, 10; GTP, 0.1; and HEPES, 10. The pH was adjusted to 7.3 with KOH.

The extracellular solution contained (mmol/L): NaCl, 140; KCl, 4; CaCl2, 1; MgCl2, 1; HEPES, 10; and glucose, 5. The pH was adjusted to 7.4 with NaOH.

2.3 HEK293 cell culture and transfection with the pcDNA3.1-hERG plasmid

HEK293 cells (ATTC, Manassas, VA, USA) were cultured. Cell cultures with good growth status were observed under a light microscope and had the following features: triangular or rhombus shaped; multiple protrusions extending outwards; clear and transparent cytoplasm; and no intracellular or extracellular impurity particles. Transfection was conducted using the Lipofectamine™ 2000 Transfection Reagent. The target plasmids were pcDNA3.1-hERG-WT (WT) and pcDNA3.1-hERG-T618I. The positive plasmid was pcDNA3.1-GFP. HEK293 cells harvested 48–72 h post-transcription. The cells were washed once with phosphate-buffered saline and digested with pancreatin for approximately 1 min. The reaction was terminated by adding culture medium. The cells were passaged at a 1:10 ratio to a 35-mm Petri dish and cultured in an incubator for 5 h. The transfected cells were observed under a fluorescence microscope and subsequently used for whole-cell patch-clamp recording.

2.4 Current record using the whole-cell patch-clamp recording method

Time dependent characteristics of current: to avoid changes in I Kr current caused by instability of membrane resistance and other conditions during recording period, I Kr current was recorded at 0, 5, 15, and 30 min after membrane breaking. It was not found that currents of WT and T618I significantly change within this time range. All the subsequent experiments were completed within ∼30 min after membrane rupture (Figure S1).

To detect the effect of DMSO on current, I Kr current was recorded when extracellular solution contained 0 (total solution volume: 3,000 μL) and 25.0 μL (total solution volume: 3,025 μL, 0.82% v/v), respectively, and it was not found that there was significant change in current amplitude under the two conditions (n = 5, P > 0.05, Figure S2).

AP was recorded in the current-clamp mode and the currents were recorded in the voltage-clamp mode. AP was stimulated to the epicardial myocardium of guinea pig, with an AP duration of approximately 180 ms. An Axon-700B clamp amplifier (Molecular Devices, Sunnyvale, CA, USA) was connected to the computer. The stimulation signals and voltage input signals were acquired using a Digidata 1440A Digitizer (Molecular Devices) and pCLAMP10.4 software. A GG-17 glass blank was drawn into a 2.0–5.5 MΩ electrode using a pp-83 glass microelectrode puller (Narishige Co., Tokyo, Japan). The 3D manipulator was adjusted for the membrane seal with a seal resistance >1.0 GΩ. Suction was applied to disrupt the membrane patch to establish the whole-cell mode. For capacitance measurement, a ramp stimulus of 0.4 V/s was applied. The current was measured and the membrane capacitance was calculated using the following equation: C m = I/(dV/dt), where C m is the membrane capacitance, I is the current, and dV/dt is the voltage slope. The value of I was represented by the current density (pA/pF) to eliminate errors between cells. The signals were passed through a fourth-order Bessel active low-pass filter with a cut-off frequency of 1 kHz and a sampling frequency of 5.0 kHz. Voltage deviation was eliminated by a series resistance compensation of 90–95%. The liquid junction potential was corrected so that the liquid junction potential was <2.0 mV. The influence of charging and discharging the membrane capacitance was eliminated by a slow capacitance compensation of 85–90%.

2.5 hERG current recording procedure and data analysis

The potential was maintained at −80 mV, and a depolarizing pulse of +20 mV for 2,000 ms was applied. The I hERG,step current was recorded. The time was 3,000 ms when the pulse was repolarized to −40 mV. The I hERG,tail current was recorded. This current was completely blocked by 1 μM dofetilide.

The potential was maintained at −80 mV, and a depolarizing pulse of −50 to +50 mV for 2,000 ms was applied with increments of 10 mV. The time was 3,000 ms when the pulse was repolarized to −40 mV. The I hERG,tail current was recorded and the current density was calculated. The stimulation pulse at each voltage was plotted on the x-axis, and the current density on the y-axis. The current–voltage (IV) dependence was observed.

The potential was maintained at −80 mV. A depolarizing pulse of +40 mV for 300 ms was applied, which was followed by a short-term hyperpolarization stimulus of −120 mV for 10 ms. This stimulus was further followed by a test stimulus of −70 to +20 mV for 100 ms. The I hERG,tail was recorded, and the inward rectification of the current was observed.

2.6 Statistical analysis

All data are expressed as the mean ± SD and processed using pCLAMP10.4 software. The data were statistically analyzed using SPSS21.0 software. Analysis of variance was used for multiple comparisons, and a Student–Newman–Keuls (SNK-q) test was performed for pairwise comparisons. A P-value of <0.05 was statistically significant.

The inhibition fraction of the peak tail current was measured. The graph is draw with the inhibitory fraction against the logarithm of the drug concentration and the mean data points were fitted with the Hill equation. The concentration of drugs needed to yield a 50% blockade of the hERG current (IC50) was obtained by fitting the data to a Hill equation: I/I 0 = 1/[1 + ([C]/IC50) nH], where I 0 and I are the current amplitudes measured in the absence and presence of drugs, respectively, [C] is the concentration of drugs in the external solution, and nH is the Hill coefficient.

3 Results

3.1 Action of Ami on the hERG-T618I current density

The I hERG-WT,tail and I hERG-T618I,tail decreased after the addition of 10 μM Ami (Figure 1a). At +50 mV, the current density for the I hERG-WT,tail decreased from 120.74 ± 9.27 to 80.61 ± 12.51 pA/pF (an approximate proportion of 33.24% ± 2.31% [n = 15]; P < 0.01). The current density for the I hERG-T618I,tail decreased from 171.17 ± 11.55 to 140.90 ± 6.17 pA/pF (an approximate proportion of 17.29% ± 1.78% [n = 15]; P < 0.05) (Figure 1b). The amplitude of the tail current before and after drug application was recorded in the same cell, and the current density was calculated using the cell capacitance. The percent inhibition of the peak tail current by Ami was measured. Inhibition fraction of drug (%) = (I beforeI after)/I before × %; I before is the amplitude of the tail current before drug application and I after is the amplitude of the tail current after drug application. Then, the inhibition fraction (%) of the tail currents was compared between WT and T618I (Figure 1c). This result indicated a significant difference in the Ami-induced blocking effect between WT and mutant currents.

Figure 1 
                  Action of Ami on the hERG-T618I current density. (a) Representative hERG-T618I and hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami; (b) after the addition of 10 μM of amiodarone (Ami), the current density of I
                     hERG-WT,tail and I
                     hERG-T618I,tail decreased significantly (all P < 0.05). The current density for the I
                     hERG-WT,tail decreased from 120.74 ± 9.27 to 80.61 ± 12.51 pA/pF (P < 0.01). The current density for the I
                     hERG-T618I,tail decreased from 171.17 ± 11.55 to 140.90 ± 6.17 pA/pF (P < 0.05); (c) the inhibition fraction (%) of the tail currents was compared between WT and T618I (P < 0.05).
Figure 1

Action of Ami on the hERG-T618I current density. (a) Representative hERG-T618I and hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami; (b) after the addition of 10 μM of amiodarone (Ami), the current density of I hERG-WT,tail and I hERG-T618I,tail decreased significantly (all P < 0.05). The current density for the I hERG-WT,tail decreased from 120.74 ± 9.27 to 80.61 ± 12.51 pA/pF (P < 0.01). The current density for the I hERG-T618I,tail decreased from 171.17 ± 11.55 to 140.90 ± 6.17 pA/pF (P < 0.05); (c) the inhibition fraction (%) of the tail currents was compared between WT and T618I (P < 0.05).

3.2 Concentration-dependent inhibition of Ami on the hERG-T618I current

Ami was added to the extracellular solution at 6 different concentrations (0.1, 0.3, 1.0, 3.0, 10.0, and 30.0 μM), and then, the effect on currents was observed. The concentration-dependent action of Ami on the I hERG-WT,tail was observed, with a half maximal inhibitory concentration (IC50) of 2.51 μM and a Hill coefficient of 1.15 (n = 12). The IC50 for the I hERG-T618I,tail was 4.56 μM and the Hill coefficient was 1.30 (n = 12). The IC50 for the mutant current was approximately 1.82 times the WT current (P < 0.05; Figure 2).

Figure 2 
                  A concentration-dependent action of the effects of Ami (0.1, 0.3, 1.0, 3.0, 10.0, and 30.0 μM) on the hERG-T618I and hERG-WT current. The IC50 for the I
                     hERG-WT,tail was 2.51 μM and a Hill coefficient of 1.15 (n = 12). The IC50 for the I
                     hERG-T618I,tail was 4.56 μM and the Hill coefficient was 1.30 (n = 12). The IC50 for the mutant current was approximately 1.82 times the WT current (P < 0.05).
Figure 2

A concentration-dependent action of the effects of Ami (0.1, 0.3, 1.0, 3.0, 10.0, and 30.0 μM) on the hERG-T618I and hERG-WT current. The IC50 for the I hERG-WT,tail was 2.51 μM and a Hill coefficient of 1.15 (n = 12). The IC50 for the I hERG-T618I,tail was 4.56 μM and the Hill coefficient was 1.30 (n = 12). The IC50 for the mutant current was approximately 1.82 times the WT current (P < 0.05).

3.3 Time-dependent characteristics of Ami inhibition

The experiments were performed to identify time-dependent features of hERG-WT and hERG-T618I mutation inhibition and washout action of the Ami. After a control period of 2 min, which demonstrated the stability of the experimental conditions, 10 µM Ami was applied to perfuse the bath. The maximal inhibition with 33.2% of the control current occurred within 4 min, and a steady-state block was obtained with a small further increase in inhibition. With the drug-free solution washout, the amplitude of hERG-WT current recovered to 80.0% of the control level in approximately 10 min. In another experiment, after a control period of 2 min, 10 µM Ami was added to the bath solution of hERG-T618I mutation cells. The maximal inhibition with 17.2% of the control current occurred within 4 min, and a steady-state block was obtained. The drug was washed out, and the current was reversed with 90% recovery within 10 min (Figure 3).

Figure 3 
                  Time-dependent characteristics of Ami inhibition. (a) After 10 µM Ami was applied to perfuse the bath, the maximal inhibition was 33.2% of the control current. With the drug-free solution washout, the amplitude of hERG-WT current recovered to 80.0% of the control level; (b) after 10 µM Ami was applied to perfuse the bath, the maximal inhibition was 17.2% of the hERG-T618I current. With the drug-free solution washout, the amplitude of hERG-T618I current was reversed with 90% recovery within 10 min.
Figure 3

Time-dependent characteristics of Ami inhibition. (a) After 10 µM Ami was applied to perfuse the bath, the maximal inhibition was 33.2% of the control current. With the drug-free solution washout, the amplitude of hERG-WT current recovered to 80.0% of the control level; (b) after 10 µM Ami was applied to perfuse the bath, the maximal inhibition was 17.2% of the hERG-T618I current. With the drug-free solution washout, the amplitude of hERG-T618I current was reversed with 90% recovery within 10 min.

3.4 Effect of Ami on activation of hERG-I618I mutant channels

As the stimulation pulse voltage shifted towards the positive potential, the current densities increased for the I hERG-WT,tail and I hERG-T618I,tail. Stability was reached when the stimulation potential was +20 mV. Both currents decreased after the addition of 10 μM Ami. The decrease in the tail current density was more significant for the I hERG-WT,tail than for the I hERG-T618I,tail (Figure 4a and b; n = 15, P < 0.05). The WT channel showed inward rectification in the STEP current stage, and the application of Ami only changed the current amplitude, but the inward rectification characteristics did not change. This result suggests that Ami acted on the activation of the channel. The WT channel did not show current attenuation at the STEP current stage, indicating that the channel remained open without inactivation. The voltage amplitude of the channel decreased significantly after the application of Ami, indicating that Ami significantly inhibited activation of the mutant channel (Figure 4c; n = 15, P < 0.05). Inactivation of the mutant channel disappeared, so the STEP current was used directly to make a steady-state activation curve. Therefore, a steady-state activation curve sloping to the right for the STEP current, which was different from the WT channel, as follows: T618I V 1/2 = 14.86241 ± 1.76483 (n = 9), curve slope k = 11.10278 ± 0.62824 (n = 9); T618I with Ami V 1/2 = 15.07437 ± 2.19289 (n = 9), curve slope k = 9.34893 ± 1.95032 (n = 9, Figure 4d; P > 0.05).

Figure 4 
                  Effect of Ami on activation of hERG-I618I mutant channels. (a) Representative hERG-T618I and hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami; (b) after the addition of 10 μM Ami, the decrease in the tail current density was more significant for the I
                     hERG-WT,tail than the I
                     hERG-T618I,tail, which was even more pronounced at >+20 mV (P < 0.05); (c) after the application of amiodarone, the inward rectification characteristics did not change in the WT channel in the STEP current stage but did not show current attenuation; however, the voltage amplitude of the channel decreased significantly (P < 0.05). (d) STEP current showed a steady-state activation curve sloping to the right, which was different from the WT channel after drug application (P > 0.05).
Figure 4

Effect of Ami on activation of hERG-I618I mutant channels. (a) Representative hERG-T618I and hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami; (b) after the addition of 10 μM Ami, the decrease in the tail current density was more significant for the I hERG-WT,tail than the I hERG-T618I,tail, which was even more pronounced at >+20 mV (P < 0.05); (c) after the application of amiodarone, the inward rectification characteristics did not change in the WT channel in the STEP current stage but did not show current attenuation; however, the voltage amplitude of the channel decreased significantly (P < 0.05). (d) STEP current showed a steady-state activation curve sloping to the right, which was different from the WT channel after drug application (P > 0.05).

3.5 Effect of Ami on inactivation of hERG-I618I mutant channels

When the current retest voltage of T618I was at 0 mV, the voltage value was the maximum. Therefore, for convenience, 0 mV voltage was also selected for voltage standardization in the WT channel. The I hERG-T618,step gradually decreased when the stimulation tended to be 0 mV due to inward rectification. As the depolarizing voltage further increased, the I hERG-T618,step decreased significantly. No considerable influence was observed on rectification after the use of Ami; however, we showed that the I hERG-T618I,step current exhibited minimal inward rectification. As the depolarizing voltage increased, the current density increased. The inward rectification of the current was partially restored after the use of Ami (Figure 5a; n = 10).

Figure 5 
                  Effect of Ami on inactivation of hERG-I618I mutant channels. (a) Representative hERG-I618I and hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami; (b) after treatment, the WT standardized current decreased from 0.85 ± 0.07 to 0.74 ± 0.07 (approximately 11.25%) at +20 mV; (c) after treatment, the normalized current of the mutant type decreased from 0.97 ± 0.07 to 0.78 ± 0.07 (approximately 19.59%) at +20 mV. Ami had a greater effect on the inward rectification of the mutant type than the WT (Figure 5b and c; n = 10; P < 0.05).
Figure 5

Effect of Ami on inactivation of hERG-I618I mutant channels. (a) Representative hERG-I618I and hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami; (b) after treatment, the WT standardized current decreased from 0.85 ± 0.07 to 0.74 ± 0.07 (approximately 11.25%) at +20 mV; (c) after treatment, the normalized current of the mutant type decreased from 0.97 ± 0.07 to 0.78 ± 0.07 (approximately 19.59%) at +20 mV. Ami had a greater effect on the inward rectification of the mutant type than the WT (Figure 5b and c; n = 10; P < 0.05).

The WT standardized current of 0.85 ± 0.07 was lower than the mutation current (0.97 ± 0.07) at +20 mV, suggesting that the mutation current was significantly reduced due to inward rectification. This finding may be the main reason for the hERG STEP current increase. After treatment, the WT standardized current decreased to 0.74 ± 0.07 (approximately 11.25%). The normalized current of the mutant type decreased to 0.78 ± 0.07 (approximately 19.59%). Ami had a greater effect on the inward rectification of the mutant type than the WT (Figure 5b and c; n = 10; P < 0.05).

The fast inactivation of hERG channels was represented as a characteristic of inward rectification in the STEP current phase. The partial recovery of inward rectification of the mutant channels by Ami suggested that Ami partially restored inactivation of the channel, but this effect was incomplete.

3.6 Action of Ami on the hERG-T618I current using the AP clamp

Figure 6 shows the changes in WT and T618I currents when a ventricular AP was applied. In early repolarization, the WT current increased slowly; however, the increase was greater and reached a maximum in late repolarization (phase 3) (Figure 6a). The conductance of the T618I current increased rapidly in early repolarization and reached a high-level plateau that was maintained as the membrane potential was repolarized, followed by a gradual decline (Figure 6b). Both currents decreased after the use of Ami, and the decrease was greater for the T618I current in early repolarization.

Figure 6 
                  Action of Ami on the hERG-T618I and hERG-WT currents using the AP clamp. (a) Representative hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami using the AP clamp and (b) representative hERG-T618I current traces recorded from cells under control conditions and after the addition of 10 μM Ami using the AP clamp. Both currents decreased after the use of Ami, and the decrease was greater for the T618I current in early repolarization.
Figure 6

Action of Ami on the hERG-T618I and hERG-WT currents using the AP clamp. (a) Representative hERG-WT current traces recorded from cells under control conditions and after the addition of 10 μM Ami using the AP clamp and (b) representative hERG-T618I current traces recorded from cells under control conditions and after the addition of 10 μM Ami using the AP clamp. Both currents decreased after the use of Ami, and the decrease was greater for the T618I current in early repolarization.

Figure 7 shows the voltage-dependent changes in hERG-WT and hERG-T618I currents when the ventricular AP clamp technique was used. The hERG-WT current changed greatly in the range of −20 to +10 mV, which indicated that the two-phase plateau current of the AP rose slowly until the AP decreased to approximately −20 mV and reached the maximum current (Figure 7a). After Ami was given, the mutant current varied greatly in the range of −10 to +10 mV and reached the maximum when the AP reached +10 mV, indicating that the current peaked at the early stage of the two-phase platform of the AP (Figure 7b). After the application of Ami, the current peak decreased, but the form did not change and the current distribution similar to the WT channel also appeared. Specifically, the current peaked at the three-phase repolarization.

Figure 7 
                  The voltage-dependent changes in hERG-WT and hERG-T618I currents when the ventricular AP clamp technique was used. (a) Representative current–voltage relationship for hERG-WT current under control conditions and after the addition of 10 μM Ami and (b) representative current–voltage relationship for hERG-T618I current under control conditions and after the addition of 10 μM Ami. After the application of amiodarone, the current peak decreased, but the form did not change, and the current distribution was similar to the WT channel.
Figure 7

The voltage-dependent changes in hERG-WT and hERG-T618I currents when the ventricular AP clamp technique was used. (a) Representative current–voltage relationship for hERG-WT current under control conditions and after the addition of 10 μM Ami and (b) representative current–voltage relationship for hERG-T618I current under control conditions and after the addition of 10 μM Ami. After the application of amiodarone, the current peak decreased, but the form did not change, and the current distribution was similar to the WT channel.

4 Discussion

SQTS is a rare hereditary disease that features an abnormally shortened QT interval in individuals with a normal heart structure. The most frequent presenting symptom of SQTS is cardiac arrest [12]. SQTS is the primary cause of atrial and ventricular arrhythmias and sudden cardiac death [12,13,14]. El-Battrawy et al. [14] reported that 71% of families with SQTS had a documented history of sudden cardiac death in a long-term follow-up study. In recent years, there have been numerous studies on the molecular mechanism underlying SQTS, which have provided evidence for diagnosing and treating SQTS [5,1517]. According to the study by Du et al., the heterogeneity of ventricular-PF repolarization may be caused by the T618I mutation, which exacerbated differences in repolarizing IhERG between PF and ventricular Aps, and consequently resulted in the U waves seen in T618I carriers [5]. Abnormal shortening of the QT interval is caused by defective functioning of both potassium and calcium ion channels, of which potassium channels are most often affected [15,16]. An hERG-T618 gain-of-function mutation that occurs in hereditary or familial SQTS has a mild impact on repolarization of the cardiac AP [6]. According to El Harchi et al., the sensitivity of the hERG-T618I current to drug application decreased by varying degrees compared to the hERH-WT current [6]. For example, the IC50 of quinidine was 0.64 nM for hERG-WT and 0.88 nM for the hERG-T618I current. The IC50 of disopyramide was 7.68 nM for WT and 16.83 nM for T618I. A similar variation in the action on the hERH-WT and hERG-T618I currents was observed for D-sotalol and flecainide. The IC50 of sotalol for T618I was 3.2 times the IC50 for WT. The IC50 of flecainide for T618I was 2.5 times the IC50 for WT. Apparently, the drug-induced inhibition on the T618I current was moderately weakened [6]. Ami is an effective antiarrhythmic drug for treating atrial and ventricular arrhythmias. Although Ami is a class III antiarrhythmic drug, Ami affects nearly all phases of the cardiac AP [7,18]. Our study showed a reduced blocking effect of Ami on the hERG-T618I current. The inhibitory effect of Ami on the T618I current was approximately one-half of the action on the WT current at the same concentration (WT, 33.24 ± 2.31% vs T618I, 17.29 ± 1.78%). The IC50 for the mutant current was approximately 1.82 times the WT current. This result indicated that the dosage of Ami should be adjusted for SQTS caused by an hERG-T618I mutation to optimize efficacy.

The fast inactivation of the mutant channel disappeared, as shown by the continuous increase in the step current. Ami effectively reduced the step current amplitude. As indicated by the right shift of the steady-state activation curve, Ami made it more difficult to activate the channel and further reduced the activated current. In contrast, after the application of Ami, the mutant channel partially recovered the characteristics of inward rectification at a higher voltage, which also indicated a partial recovery of the inactivation of the channel, but this inactivation was incomplete. Both mechanisms are involved in the effect of Ami on mutant channels. Further AP clamp experiments confirmed that Ami significantly decreased the channel current in the early stage of AP repolarization but did not appear to slowly increase similar to the WT. This finding suggested that Ami mainly affected channel activation but did not have a major role in recovery of the channel inactivation function [15,16].

We only studied the action of Ami on the hERG-T618I current alone by excluding the interferences of all other currents. In this way, we more clearly understood how Ami acted on the hERG-T618I current; however, the electrical activity of the heart is the result of the coordinated action of several ion currents [19,20]. What may happen after the Ami-induced blocking of the hERG-T618I current remains to be further investigated.

To conclude, Ami inhibited the hERG-T618I current in HEK293 cells, but the inhibition was less intense than WT hERG. It is therefore necessary to adjust the dosage and treatment regimen if patients have SQT1 caused by a hERG-T618I mutation.


tel: +86-10-66936762

Acknowledgments

This study was supported by Special project of advantageous discipline of Fujian University of Traditional Chinese Medicine (No. X2022015).

  1. Funding information: This study was supported by the National Natural Science Foundation of China (No. 82070328) and the Special Subjects of Advantageous Disciplines of Fujian University of Chinese Medicine (No. X2022015 – Special)

  2. Author contributions: M.L. and C.L. concepted the study, designed the experiments, provided the investigation and methods supports, and wrote the manuscript. C.L., S.X., Q.X., and Y.L. did the experiments and acquired the data. M.L. did the data analysis and statistical analysis, and C.L. did the data validations. C.L., S.X., Q.X., and Y.L. critically revised the article. The authors declare that this work was done by the author(s) named in this article and all liabilities pertaining to claims relating to the content of this article will be borne by the authors. The authors applied the SDC approach for the sequence of the authors. All authors have approved the final draft of article before submission.

  3. Conflict of interest: Authors state no conflicts of interests.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175–87.10.1016/S0092-8674(00)80728-XSearch in Google Scholar

[2] Butler A, Helliwell MV, Zhang Y, Hancox JC, Dempsey CE. An update on the structure of hERG. Front Pharmacol. 2020;10:1572.10.3389/fphar.2019.01572Search in Google Scholar PubMed PubMed Central

[3] Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature. 2006;440:463–9.10.1038/nature04710Search in Google Scholar PubMed

[4] Sun Y, Quan XQ, Fromme S, Cox RH, Zhang P, Zhang L, et al. A novel mutation in the KCNH2 gene associated with short QT syndrome. J Mol Cell Cardiol. 2011;50:433–41.10.1016/j.yjmcc.2010.11.017Search in Google Scholar PubMed

[5] Du C, Zhang H, Harmer SC, Hancox JC. Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG ‘hotspot’ mutation. Biochem Biophys Res Commun. 2022;596:49–55.10.1016/j.bbrc.2022.01.057Search in Google Scholar PubMed PubMed Central

[6] El Harchi A, Melgari D, Zhang YH, Zhang H, Hancox JC. Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel. PLoS One. 2012;7:e52451.10.1371/journal.pone.0052451Search in Google Scholar PubMed PubMed Central

[7] Hamilton D, Sr, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C, et al. Amiodarone: A comprehensive guide for clinicians. Am J Cardiovasc Drugs. 2020;20:549–8.10.1007/s40256-020-00401-5Search in Google Scholar PubMed

[8] Pannone L, D’Angelo G, Gulletta S, Falasconi G, Brugliera L, Frontera A, et al. Amiodarone in ventricular arrhythmias: Still a valuable resource? Rev Cardiovasc Med. 2021;22:1383–92.10.31083/j.rcm2204143Search in Google Scholar PubMed

[9] Furutani K, Yamakawa Y, Inanobe A, Iwata M, Ohno Y, Kurachi Y. A mechanism underlying compound-induced voltage shift in the current activation of hERG by antiarrhythmic agents. Biochem Biophys Res Commun. 2011;415:141–6.10.1016/j.bbrc.2011.10.034Search in Google Scholar PubMed

[10] Zhang Y, Colenso CK, El Harchi A, Cheng H, Witchel HJ, Dempsey CE, et al. Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking. Biochem Pharmacol. 2016;113:24–35.10.1016/j.bcp.2016.05.013Search in Google Scholar PubMed PubMed Central

[11] Lin M. Electrophysiological characteristics of the T618I mutant hERG potassium channels and drug reactivity by beads marked method. Fujian: Fujian Medical University; 2012.Search in Google Scholar

[12] Hancox JC, Du CY, Butler A, Zhang Y, Dempsey CE, Harmer SC, et al. Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome. Philos Trans R Soc Lond B Biol Sci. 2023;378(1879):20220165.10.1098/rstb.2022.0165Search in Google Scholar PubMed PubMed Central

[13] Campuzano O, Sarquella-Brugada G, Cesar S, Arbelo E, Brugada J, Brugada R. Recent advances in short QT syndrome. Front Cardiovasc Med. 2018;5:149.10.3389/fcvm.2018.00149Search in Google Scholar PubMed PubMed Central

[14] El-Battrawy I, Besler J, Liebe V, Schimpf R, Tülümen E, Rudic B, et al. Long-term follow-up of patients with short QT syndrome: Clinical profile and outcome. J Am Heart Assoc. 2018;7:e010073.10.1161/JAHA.118.010073Search in Google Scholar PubMed PubMed Central

[15] Dewi IP, Dharmadjati BB. Short QT syndrome: The current evidences of diagnosis and management. J Arrhythm. 2020;36:962–6.10.1002/joa3.12439Search in Google Scholar PubMed PubMed Central

[16] Khera S, Jacobson JT. Short QT syndrome in current clinical practice. Cardiol Rev. 2016;24:190–3.10.1097/CRD.0000000000000091Search in Google Scholar PubMed

[17] Perike S, Mc CM. Molecular insights into the short QT syndrome. J Innov Card Rhythm Manag. 2018;2018:3065–70.10.19102/icrm.2018.090302Search in Google Scholar PubMed PubMed Central

[18] Mujović N, Dobrev D, Marinković M, Russo V, Potpara TS. The role of amiodarone in contemporary management of complex cardiac arrhythmias. Pharmacol Res. 2020;151:104521.10.1016/j.phrs.2019.104521Search in Google Scholar PubMed

[19] Padeletti L, Bagliani G. Normal electrophysiology, substrates, and the electrocardiographic diagnosis of cardiac arrhythmias. Card Electrophysiol Clin. 2017;9:xi–xii.10.1016/j.ccep.2017.07.001Search in Google Scholar PubMed

[20] Zhou Y, Hao Y, Sun P, Li G, Dong M, Fan X, et al. New understanding of electrical activity brought by surface potential of cardiomyocytes. Sci Rep. 2021;11:6593.10.1038/s41598-021-86138-wSearch in Google Scholar PubMed PubMed Central

Received: 2023-07-11
Revised: 2023-09-05
Accepted: 2023-09-08
Published Online: 2023-11-03

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 27.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0749/html
Scroll to top button